Abstract
Although many Americans take vitamins and supplements, there is little objective data available regarding their benefits and risks, and they are not tightly regulated by the FDA. Studies of multivitamins and anti-oxidant pills have not shown them to be effective in disease prevention. The benefits and risks of eye vitamins, fish oil, Vitamin E, and Folic Acid are also assessed. There continues to be confusion regarding the benefits and risks of supplement use. Information presented to doctors and patients tends to be misleading and difficult to interpret. This is due, in large part, to the use of relative risks rather than absolute values when communicating information on supplement benefits. In light of this situation, a unique graphic, functioning as a decision aid, has been developed to enable physicians and patients to jointly assess the benefits and risks of vitamin and supplement use. By characterizing the complexities of risk analysis in terms patients can understand, means they will be able to make well-informed decisions about their health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
HOPE-TOO Trial Investigators. (2005). Long term vitamin e supplements in patients with vascular disease or diabetes. Journal of American Medical Association, 2005(293), 138–147.
Miller, E. R., et al. (2005). Meta-analysis: High-dosage vitamin e supplementation may increase all-cause mortality. Annals of Internal Medicine, 142(1), 37–46.
Klein, E. A., et al. (2011). Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial. Journal of American Medical Association, 306, 1549–1555.
Searing, L. (2014). A daily dose of vitamin E may slow early Alzheimer’s disease. The Washington Post, 4(2014), E3.
Miller, E. R., et al. (2010). Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. American Journal of Cardiology, 106(4), 517–527.
Clark, R., et al. (2010). Effects of lowering homocysteine levels with b vitamins on cardiovascular disease, cancer, and cause-specific mortalitymeta-analysis of 8 randomized trials involving 37,485 individuals. Archives of Internal Medicine, 170(18), 1622–1631.
Albert, C. M., et al. (2008). Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among females at high risk for cardiovascular disease. Journal of American Medical Association, 2008(299), 2027–2031.
Kwak, S., et al. (2012). Efficacy of omega-3 fatty acid supplements in the secondary prevention of cardiovascular disease. Archives of Internal Medicine, 175(9), 686–694.
Risk and Prevention Study Collaborative Group. (2013). N-3 fatty acids in patients with multiple cardiovascular risk factors. New England Journal of Medicine, 368, 1800–1808.
Rizos, E., et al. (2012). Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. Journal of American Medical Association, 308(10), 1024–1033.
Brasky, T. M., et al. (2013). Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. Journal of the National Cancer Institute, 105(15), 1132–1141.
Gellar, E., et al. (2013). Enough is enough: Stop wasting money on vitamin and mineral supplements. Annals of Internal Medicine, 159(12), 850–851.
Fortmann, S., et al. (2013). Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. preventive services task force. Annals of Internal Medicine, 159(12), 824–834.
Myung, S., et al. (2013). Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. British Medical Journal, 346, f10.
Bjelakovic, G., et al. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. Journal of American Medical Association, 2007(297), 842–857.
Bjelakovic, G., et al. (2013). Antioxidant supplements to prevent mortality. Journal of American Medical Association, 310, 1178–1179.
Group, A.-R. E. D. S. R. (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e, beta carotene, and zinc for age-related macular degeneration and vision loss. Archives of Ophthalmology, 119(10), 1417–1436.
The alpha-tocopherol, beta carotene cancer prevention study group. (1994). The effect of vitamin e and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine, 330(15), 1029–1035.
Omenn, G., et al. (1996). Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. Journal of the National Cancer Institute, 1996(88), 1550–1559.
Snitz, B. E., et al. (2009). Ginkgo Biloba for preventing cognitive decline in older adults. Journal of the American Medical Association, 302, 2663.
Grodstein, F., et al. (2013). Long-term multivitamin supplementation and cognitive function in men: A randomized trial. Annals of Internal Medicine, 159(12), 806–814.
Hishikawa, N., et al. (2012). Effect of tumeric on Alzheimer’s disease with behavior and psychological symptoms of dementia. An International Quarterly Journal of Research in Ayurveda, 33(4), 499–504.
Baker, W., et al. (2008). Effect of cinnamon on glucose control and lipid parameters. Diabetes Care, 3(1), 41–43.
Hemila, H., et al. (2013). Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Review, 1, CD000253.
Barrett, B., et al. (2011). Placebo effects and the common cold: A randomized controlled trial. Annals of Family Medicine, 2011(9), 312–327.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rifkin, E., Lazris, A. (2015). Vitamins and Supplements. In: Interpreting Health Benefits and Risks. Springer, Cham. https://doi.org/10.1007/978-3-319-11544-3_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-11544-3_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11543-6
Online ISBN: 978-3-319-11544-3
eBook Packages: MedicineMedicine (R0)